Albion Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.3M | Buy |
120,147
+410
| +0.3% | +$70.1K | 1.31% | 22 |
|
|
2025
Q4 | $20.2M | Sell |
119,737
-3,615
| -3% | -$587K | 1.26% | 22 |
|
|
2025
Q3 | $17.8M | Sell |
123,352
-641
| -0.5% | -$87.5K | 1.08% | 28 |
|
|
2025
Q2 | $15.7M | Buy |
123,993
+172
| +0.1% | +$21.1K | 1.02% | 29 |
|
|
2025
Q1 | $15.8M | Sell |
123,821
-4,877
| -4% | -$661K | 1.12% | 24 |
|
|
2024
Q4 | $17M | Sell |
128,698
-1,282
| -1% | -$180K | 1.16% | 26 |
|
|
2024
Q3 | $18.9M | Buy |
129,980
+356
| +0.3% | +$51.5K | 1.31% | 24 |
|
|
2024
Q2 | $17.8M | Buy |
129,624
+14
| +0% | +$1.87K | 1.34% | 21 |
|
|
2024
Q1 | $17.8M | Buy |
129,610
+233
| +0.2% | +$31.8K | 1.37% | 21 |
|
|
2023
Q4 | $17.6M | Buy |
129,377
+1,575
| +1% | +$192K | 1.45% | 20 |
|
|
2023
Q3 | $15.6M | Buy |
127,802
+7,375
| +6% | +$938K | 1.44% | 21 |
|
|
2023
Q2 | $15.3M | Sell |
120,427
-9,287
| -7% | -$1.21M | 1.34% | 22 |
|
|
2023
Q1 | $16.8M | Buy |
129,714
+784
| +0.6% | +$103K | 1.53% | 17 |
|
|
2022
Q4 | $16.9M | Buy |
128,930
+38
| +0% | +$4.91K | 1.63% | 18 |
|
|
2022
Q3 | $15.1M | Buy |
128,892
+835
| +0.7% | +$104K | 1.56% | 17 |
|
|
2022
Q2 | $15.1M | Buy |
128,057
+4,424
| +4% | +$525K | 1.49% | 17 |
|
|
2022
Q1 | $16.1M | Buy |
123,633
+2,403
| +2% | +$313K | 1.37% | 20 |
|
|
2021
Q4 | $18.5M | Buy |
121,230
+2,831
| +2% | +$438K | 1.47% | 19 |
|
|
2021
Q3 | $19.1M | Buy |
118,399
+8,748
| +8% | +$1.47M | 1.68% | 14 |
|
|
2021
Q2 | $17.9M | Buy |
+109,651
| New | +$16.9M | 1.56% | 17 |
|
|
2020
Q4 | $15.9M | Buy |
104,655
+3,307
| +3% | +$473K | 1.55% | 18 |
|
|
2020
Q3 | $13.7M | Buy |
101,348
+561
| +0.6% | +$76.1K | 1.49% | 19 |
|
|
2020
Q2 | $13.8M | Buy |
100,787
+1,347
| +1% | +$172K | 1.63% | 16 |
|
|
2020
Q1 | $10.7M | Buy |
99,440
+1,698
| +2% | +$195K | 1.56% | 18 |
|
|
2019
Q4 | $11.8M | Buy |
97,742
+673
| +0.7% | +$75.1K | 1.4% | 24 |
|
|
2019
Q3 | $9.66M | Sell |
97,069
-5,773
| -6% | -$604K | 1.24% | 25 |
|
|
2019
Q2 | $11.2M | Sell |
102,842
-1,659
| -2% | -$176K | 1.45% | 23 |
|
|
2019
Q1 | $11.7M | Buy |
104,501
+2,926
| +3% | +$321K | 1.58% | 18 |
|
|
2018
Q4 | $9.79M | Buy |
101,575
+1,273
| +1% | +$135K | 1.53% | 21 |
|
|
2018
Q3 | $12.2M | Buy |
100,302
+1,919
| +2% | +$226K | 1.65% | 19 |
|
|
2018
Q2 | $10.8M | Buy |
98,383
+1,104
| +1% | +$118K | 1.56% | 20 |
|
|
2018
Q1 | $10.4M | Buy |
97,279
+444
| +0.5% | +$49.2K | 1.6% | 20 |
|
|
2017
Q4 | $10.3M | Sell |
96,835
-254
| -0.3% | -$27.1K | 1.57% | 21 |
|
|
2017
Q3 | $10.8M | Buy |
97,089
+7,632
| +9% | +$816K | 1.65% | 16 |
|
|
2017
Q2 | $9.25M | Buy |
89,457
+150
| +0.2% | +$14.8K | 1.54% | 19 |
|
|
2017
Q1 | $8.73M | Buy |
89,307
+82,104
| +1,140% | +$7.86M | 1.31% | 20 |
|
|
2016
Q4 | $637K | Sell |
7,203
-60
| -0.8% | -$5.46K | 0.11% | 104 |
|
|
2016
Q3 | $701K | Buy |
+7,263
| New | +$691K | 0.12% | 104 |
|
|
2016
Q1 | – | Sell |
-88,008
| Closed | -$9.93M | – | 187 |
|
|
2015
Q4 | $9.93M | Buy |
88,008
+135
| +0.2% | +$14.7K | 1.71% | 16 |
|
|
2015
Q3 | $8.88M | Buy |
87,873
+489
| +0.6% | +$58.7K | 1.61% | 17 |
|
|
2015
Q2 | $10.7M | Buy |
87,384
+576
| +0.7% | +$69K | 1.79% | 14 |
|
|
2015
Q1 | $9.94M | Buy |
86,808
+2,181
| +3% | +$241K | 1.69% | 14 |
|
|
2014
Q4 | $8.56M | Sell |
84,627
-54,678
| -39% | -$5.31M | 1.48% | 19 |
|
|
2014
Q3 | $12.7M | Buy |
139,305
+1,014
| +0.7% | +$89K | 2.25% | 11 |
|
|
2014
Q2 | $11.8M | Buy |
138,291
+6,609
| +5% | +$521K | 2.05% | 11 |
|
|
2014
Q1 | $10.4M | Buy |
131,682
+5,295
| +4% | +$441K | 1.91% | 12 |
|
|
2013
Q4 | $9.57M | Buy |
126,387
+405
| +0.3% | +$28.7K | 1.79% | 13 |
|
|
2013
Q3 | $8.8M | Buy |
125,982
+11,034
| +10% | +$723K | 1.88% | 12 |
|
|
2013
Q2 | $6.66M | Buy |
+114,948
| New | +$6.64M | 1.48% | 22 |
|
Other funds holding IBB
CB
Albion Financial Group's IBB Position: Q1 2026 in Review
Albion Financial Group increased its iShares Biotechnology ETF (IBB) stake by 0.34% in Q1 2026, buying an estimated $70.1K and bringing the position to 120,147 shares worth $20.3M. The position accounts for 1.31% of the portfolio, ranked #22.
Albion Financial Group first reported a position in IBB in Q2 2013 and has held it in 49 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Albion Financial Group held 120,147 shares of iShares Biotechnology ETF worth $20.3M as of Q1 2026.
- Albion Financial Group bought 410 iShares Biotechnology ETF shares in Q1 2026, an estimated $70.1K.
- iShares Biotechnology ETF made up 1.31% of Albion Financial Group's portfolio in Q1 2026, its #22 holding.
- Albion Financial Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 49 quarters since.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.